HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION IN-VIVO TRACKED BY DNA HETERODUPLEX MOBILITY ASSAYS

被引:273
|
作者
DELWART, EL
SHEPPARD, HW
WALKER, BD
GOUDSMIT, J
MULLINS, JI
机构
[1] STANFORD UNIV,SCH MED,DEPT IMMUNOL & MICROBIOL,STANFORD,CA 94305
[2] CALIF DEPT HLTH SERV,VIRAL & RICKETTSIAL DIS LAB,BERKELEY,CA 94704
[3] MASSACHUSETTS GEN HOSP,INFECT DIS UNIT,BOSTON,MA 02114
[4] UNIV AMSTERDAM,ACAD MED CTR,HUMAN RETROVIRUS LAB,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1128/JVI.68.10.6672-6683.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
High mutation rates and strong selective pressures imposed on human immunodeficiency viruses in vivo result in the formation of pools of genetic variants known as quasispecies. DNA heteroduplex mobility and tracking analyses were used to monitor the generation of HIV sequence diversity, to estimate quasispecies complexity, and to assess the turnover of genetic variants to approach an understanding of the relationship between viral quasispecies evolution in vivo and disease progression. Proviral DNA pools were nearly homogeneous soon after sexual transmission. The emergence and clearance of individual variants then occurred at different rates in different individuals. High quasispecies complexity was found in long-term-infected, asymptomatic individuals, while rapid CD4(+) cell decline and AIDS were often, but not always, associated,vith lower quasispecies complexity. Proviral genetic variation was often low following in vitro culture, because of the outgrowth of one or a few variants that often became more abundant only later as proviruses in peripheral blood mononuclear cells. These studies provide insight into the dynamics of human immunodeficiency virus sequence changes in vivo and illustrate the utility of heteroduplex analysis for the study of phenomena associated with rapid genetic changes.
引用
收藏
页码:6672 / 6683
页数:12
相关论文
共 50 条
  • [31] GENETIC SUBTYPING OF HUMAN-IMMUNODEFICIENCY-VIRUS USING A HETERODUPLEX MOBILITY ASSAY
    DELWART, EL
    HERRING, B
    RODRIGO, AG
    MULLINS, JI
    PCR-METHODS AND APPLICATIONS, 1995, 4 (05): : S202 - S216
  • [32] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [33] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [34] SEQUENCES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 U3 REGION REQUIRED FOR IN-VIVO AND IN-VITRO INTEGRATION
    REICIN, AS
    KALPANA, G
    PAIK, S
    MARMON, S
    GOFF, S
    JOURNAL OF VIROLOGY, 1995, 69 (09) : 5904 - 5907
  • [35] IN-VITRO AND IN-VIVO BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN AND SP1 TRANSCRIPTION FACTOR
    JEANG, KT
    CHUN, R
    LIN, NH
    GATIGNOL, A
    GLABE, CG
    FAN, H
    JOURNAL OF VIROLOGY, 1993, 67 (10) : 6224 - 6233
  • [36] INTRAHOST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION IS RELATED TO LENGTH OF THE IMMUNOCOMPETENT PERIOD
    LUKASHOV, VV
    KUIKEN, CL
    GOUDSMIT, J
    JOURNAL OF VIROLOGY, 1995, 69 (11) : 6911 - 6916
  • [37] DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES MAY NOT BE REQUIRED FOR INFECTIVITY
    ARTS, EJ
    MAK, J
    KLEIMAN, L
    WAINBERG, MA
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 1605 - 1613
  • [38] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS
    AIKEN, C
    TRONO, D
    JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056
  • [39] RAPID ENZYMATIC ANALYSIS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA IN CLINICAL SPECIMENS
    SEVALL, JS
    PRINCE, H
    GARRATTY, G
    OBRIEN, WA
    ZACK, JA
    CLINICAL CHEMISTRY, 1993, 39 (03) : 433 - 439
  • [40] MOLECULAR-BIOLOGY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HASELTINE, WA
    FASEB JOURNAL, 1991, 5 (10): : 2349 - 2360